The presence of cardiac troponin I in the serum is now considered as o
ne of the most specific biochemical markers of acute myocardial infarc
tion. To improve the knowledge of the antigenic properties of cardiac
Troponin I, a set of monoclonal antibodies and polyclonal antibodies a
gainst human cardiac troponin I has been tested with overlapping pepti
des covering the cardiac troponin I sequence. The results indicate tha
t N-terminal and C-terminal cardiac troponin I regions were most often
recognized by poly- and monoclonal antibodies. These observations are
valuable for choosing the best combination of monoclonal antibodies t
o set up new immunoassays to detect serum cardiac troponin I earlier a
fter myocardial damage, to understand better which forms are released,
and finally to propose appropriate cardiac troponin I standards.